Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4007340 | Archivos de la Sociedad Española de Oftalmología | 2012 | 4 Pages |
Abstract
CNV has been reported to occur in 72% to 86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
A. González-Gómez, M.J. Morillo, A.B. González-Escobar, J.M. GarcÃa-Campos,